Skip to main content
← DISPATCHES
[LIFE]

Briefing: Gene edit makes probiotic safer for immunocompromised patients

Strategic angle: An international team of researchers has modified a probiotic yeast to enhance safety for vulnerable populations.

Editorial Staff · 2026-03-09 · 1 MIN READ

Summary

  • Modified yeast reduces infection risk for immunocompromised individuals.
  • Research conducted using animal models.
  • Target groups include older adults and infants.

Key Facts

Fact Value
Research Team International team of researchers
Target Population Immunocompromised patients, older adults, infants
Testing Method Animal model

Sources